Vyant Bio Inc is a vital new force in drug discovery. Its AnalytiX platform, at the intersection of human biology and machine learning, is unmatched in its ability to analyze robust functional data to identify drug candidates. Its proprietary microOrgan technology uses functional microtissues engineered from induced pluripotent stem cells (iPSC) to facilitate high-throughput, human-based drug discovery without the risks or delayed timing of testing drugs in humans.